Even the simplest of medical device recalls represents a complex undertaking—one in which a lack of clear communication can be devastating when it comes to protecting patient safety. The process becomes infinitely harder when you layer on involvement by multiple manufacturers, particularly given the dated nature of the recall process itself.
Over the past year, the road leading up to the recent sweeping syringe recalls, due to compatibility issues with pumps and manufacturing challenges, has underscored just how wrong things can go when notification systems aren’t built with clarity and speed in mind. Here’s some brief background and a timeline of events leading up to the syringe recall:
- Pre-June 2023: Cardinal Health acquires Covidien’s line of syringes from Medtronic.
- June 2023: Cardinal introduces the re-engineered syringes, now branded with the Cardinal logo.
- Sept. 20, 2023: Cardinal notifies customers of compatibility issues with BD pumps through an “urgent medical device report,” not yet labeling it a recall.
- Sept. 27, 2023: A second notification expands the alert to more sizes.
- Oct. 19, 2023: Concurrent recalls by B. Braun and Fresenius complicate the syringe supply situation further.
- Nov. 15, 2023: The FDA categorizes the situation as a Class I recall, indicating the serious potential for harm.
- Nov. 16, 2023: Additional recalls from Fresenius and Baxter for infusion pumps (which use syringes) are announced.
- Nov. 21, 2023: FDA clarifies the recall to include PCA pumps, highlighting an omission in previous communications.
- Feb. 2, 2024: Cardinal Health announces a voluntary product removal of all sizes of certain Monoject syringes due to compatibility and performance issues.
- March 7, 2024: FDA updates its website to reflect the product removal, indicating a significant delay in public communication.
- March 18, 2024: FDA issues warning letters to Medline Industries and Sol-Millenium Medical for selling unauthorized plastic syringes from a Chinese manufacturer.
- April 24, 2024: FDA issues warning to Cardinal Health for selling unapproved syringes from Chinese manufacturer.
- May 20, 2024: More China-based syringe manufacturers received import alert from the FDA.
- May 23, 2024: Medline issues recall for Chinese manufactured syringes.
Confusing? You bet. And this is just the tip of the iceberg when it comes to the problems that plague today’s medical device recall process.
Challenges faced by hospital staff
The timeline above illustrates the evolving and complex nature of many recalls. This one has unfolded over several months and has involved multiple communications, inter-related products, expansions and updates.
Hospital staff, tasked with ensuring patient safety, face significant challenges when it comes to recalls like this. Those challenges include:
- Staying informed: Keeping up with the initial alerts, subsequent updates, and clarifications is difficult. The current system to notify healthcare provider organizations often results in duplicate and triplicate alerts being received for the same recall, but spaced out so much in time that hospital staff end up working the same recall again. When you add the multiple different communications and expansions, such as in this case, the resulting process is very far from optimal. Consider now introducing another variable: lag. Currently, on average, hospitals receive paper recall notifications 16-plus days after the manufacturer sends a FedEx letter to them. In addition, syringes are typically managed through distribution centers, adding another layer of complexity and notification to the notification process. Distributors are required by law to alert customers of recalls in addition to the manufacturer.
- Inventory management: Identifying and segregating affected products requires constant vigilance and resources. Today, many providers are checking the shelves five times more than would be needed if the process was efficient. This doesn’t seem like much until you consider the number of recalls a hospital needs to look at and consider every year. The above process results in the hospital starting the process to source a new syringe several days after the notification. Receiving and restocking can take 24-72 hours (about 3 days), delaying caregivers’ ability to use appropriate product with patients.
- Patient care impact: In this case, the potential for delayed treatment or incorrect dosing posed risks to patient care. The reality is patients could be impacted by most recalls, for many more days than necessary given current processes.
The need for a universal electronic platform
Cases like this one underscore the urgent need for a universal electronic platform for recall communications. Such a platform offers:
- Real-time alerts: A universal electronic platform offers immediate dissemination of recall notices and updates. Notifications are received less than 60 seconds after a manufacturer or distributor sends it.
- Centralized information: A universal electronic platform is a one-stop source for all recall-related information, reducing the need for cross-referencing multiple communications. A centralized hub allows a provider to quickly look up what has been done for a specific recall, eliminating the risk of confusion resulting in inaction.
- Direct linking of communications: A universal electronic platform ensures that updates are clearly connected to initial alerts, providing a coherent timeline of events. Updates and evolving details of a specific recall are communicated and maintained in a single record, even when there are multiple updates over a long period of time.
- Enhanced efficiency: A universal electronic platform saves valuable time and resources for healthcare providers, allowing them to focus on patient care. Such a system helps hospitals avoid re-work for front-line caregivers, sourcing, value analysis teams and leadership.
The syringe recall debacle, and all its related offshoots, exemplifies the intricate challenges and significant impacts associated with medical device recalls. Even since the initial writing of this article, the situation has been further complicated by yet another syringe recall that will require hospital resources to sort out.
The situation underscores the critical need for an improved approach to recall communication, including the adoption of a universal electronic platform. Such a system would represent a paradigm shift, promising to enhance patient safety, streamline hospital operations, and maintain the integrity of medical device manufacturers. As the landscape of medical technology evolves, the implementation of such platforms becomes increasingly vital, ensuring the highest standards of patient care and operational efficiency in the face of complex recall challenges.
Picture: z_wei, Getty Images
Guillermo Ramas is a healthcare technology executive and entrepreneur with more than 30 years of experience advancing innovation across the healthcare supply chain. He is the founder of NotiSphere, a digital platform designed to modernize how medical device recalls and supply disruptions are communicated and executed between manufacturers, distributors, and healthcare providers.
Following NotiSphere’s acquisition by PAR Excellence Systems in 2024, Guillermo serves as Executive Advisor, Business Development & Strategic Alliances, where he focuses on supplier strategy, platform integration, and expanding the digital infrastructure that underpins supply chain visibility and regulatory performance.
Throughout his career, he has worked closely with manufacturers, distributors, and health systems on post-market surveillance, recall execution, and patient safety initiatives. His work centers on closing the gap between regulatory intent and operational reality, and on building shared technology frameworks that reduce systemic risk and strengthen trust across the healthcare ecosystem.
This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.
